Cash cost of the wait: management is funding a defined waiting period whose end is already scheduled
The model's full reasoning — Q4 2015 call → NOWe need to determine if the transcript describes a situation where the company is currently living through a defined waiting period it is paying for out of its own pocket, with a specific near-dated event at the end, and management treats it as the main current work. Let's examine the transcript for such a situation. Key points from the call: - They mention a new flexible press and laminator being added in the first half of this year. That is an investment, but they are already growing in flexibles. Not a waiting period. - They mention a new plant in Malaysia for composite cans, ramping up production throughout 2016. That could be a waiting period: they are paying for the plant, but it's not yet fully utilized. However, they say "we will ramp up production at this facility throughout 2016." That is a ramp-up, but is it a defined waiting period with a specific near-dated event? They don't give a specific date when it will be fully operational. Also, they are expanding internationally, but it's not clear that they are currently bearing a cost with no benefit yet. They might be already producing. - They mention a new EvoCan line at their composite can plant in Chicago, starting up later this year. That is a future start-up. But is it a waiting period they are paying for now? They are investing, but they don't describe it as a current cost burden. - They mention the TruVue container (ClearView?) - they are expecting to release it in early second quarter. They have been developing it, and they have customer engagements. They say "we are anxious to get it on the shelf" and they have made progress. But is the company currently paying for something that is not yet earning? They have been developing it, but they don't describe a specific cost they are bearing now with no return. They might have R&D costs, but that's normal. - They mention the Weidenhammer acquisition integration, which is done and accretive. - They mention the sale of a paper mill in France, but that's a divestiture. - They mention the loss of a contract with a customer in Irapuato, Mexico, which will transition over six months. That is a loss, not a waiting period. - They mention the corrugating medium machine is a drag, but that's due to market conditions, not a self-funded waiting period. - They mention manufacturing productivity was weaker than targets, but they are focusing on improving it.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| KOPN | Kopin Corporation | Q4 2023 | 2024-03-14 | C+ |
| LILA | Liberty Latin America Ltd. | Q4 2023 | 2024-02-23 | C |
| SBS | Companhia de Saneamento Básico do Estado | Q3 2023 | 2023-11-10 | C+ |
| QTRX | Quanterix Corporation | Q3 2023 | 2023-11-07 | B |
| APPS | Digital Turbine, Inc. | Q1 2024 | 2023-08-08 | D |
| PRPH | ProPhase Labs, Inc. | Q1 2023 | 2023-05-11 | F |
| CDE | Coeur Mining, Inc. | Q1 2023 | 2023-05-11 | C+ |
| SOL | ReneSola Ltd | Q3 2022 | 2022-12-01 | C+ |
| FLL | Full House Resorts, Inc. | Q3 2022 | 2022-11-07 | B |
| EHTH | eHealth, Inc. | Q2 2021 | 2021-07-29 | F |
| IRT | Independence Realty Trust, Inc. | Q2 2018 | 2018-08-02 | B |
| YUM | Yum! Brands, Inc. | Q2 2018 | 2018-08-02 | C |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| FLEX | Flex Ltd. | Q1 2018 | 2017-07-28 | F |
| DAN | Dana Incorporated | Q1 2017 | 2017-05-02 | B |
SBS · Q3 2023 → YESThe question is whether management describes the company as currently living through a defined waiting period it's paying for out of its own pocket. YES The transcript shows management describing the company as currently bearing real, ongoing cash costs (salaries, consulting, transition work) for the IDP/restructuring program whose benefits (full expense reduction, shared-services center operational) are not yet realized. The far side is a specific, near-dated event: full 3.7% staff reduction and shared-services center operational by mid-2024 (July 2024 for full benefit), with the program already in motion and on schedule. Management frames this as the main current work, not a setback, and treats the costs as self-funded. This meets all three conditions.
EHTH · Q2 2021 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing the company as currently living through a defined waiting period for the AEP, paying for it out of its own pocket through heavy investments in internal agents and quality initiatives. They hired agents early, many still in training with lower productivity, and are bearing the cost of additional training and customer service expansion in Q3. This is framed as a chosen investment to improve enrollment quality and prepare for the fourth-quarter AEP, not an apology or external issue.
YUM · Q2 2018 → YESThe question is whether management describes the company as currently living through a defined waiting period it is paying for out of its own pocket. YES The transcript shows management describing a clear, self-funded transition cost tied to the refranchising effort. They explicitly call out the “timing mismatch between G&A savings and refranchising” as one of the four items weighing on Q2 core operating profit, and they quantify the full-year headwind at 6 7 percentage points. This is presented as a real, ongoing drag on current results while they complete the shift to 98 % franchised by year-end 2018 and reach the 1.7 % G&A run-rate target in 2019.